We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Global Market for Biomarker-Based Infectious Disease Tests to Surpass USD 20 Billion in 2027

By HospiMedica International staff writers
Posted on 22 May 2023
Print article
Image: The global market for infectious disease-based tests using biomarkers is projected to reach USD 20.7 billion in 2027 (Photo courtesy of Freepik)
Image: The global market for infectious disease-based tests using biomarkers is projected to reach USD 20.7 billion in 2027 (Photo courtesy of Freepik)

Biomarkers encompass over a thousand substances utilized as reagents, consumables, and/or test components for a variety of diagnostics and medical research procedures. They also include substances that can detect and measure genetic alterations in patient samples. Biomarkers for infectious diseases include proteins (antigens), antibodies generated due to the presence of infectious agents, and genetic markers. Recent advancements like mass spectrometry are being employed for pathogen identification. The global market for infectious disease tests that utilize biomarkers is anticipated to expand at a compound annual growth rate (CAGR) of 5.8% from USD 14.8 billion in 2021 to USD 20.7 billion in 2027, fueled by factors such as an aging population with higher disease vulnerability, an increase in targeted therapies, and a large and expanding clinical diagnostic test market.

These are the latest findings of Kalorama Information (Arlington, VA, USA), a leading publisher of market research in medical markets.

Laboratory immunoassays are expected to account for more than 60% of global infectious disease biomarker sales over the long term. This can be attributed to the technology’s ability in detecting a wide range of common pathogens, including antigens or antibodies associated with pneumonia, influenza, Clostridium difficile (C. diff), hepatitis C, HIV, herpes simplex virus (HSV), and Lyme disease. Enzyme-linked immunoassays are especially suitable for diagnosing these diseases. In the case of more complex infectious disease testing applications, polymerase chain reaction (PCR), microarrays, and other molecular technologies are likely to garner a higher share of the global value and volume. These technologies are capable of identifying DNA, RNA, and genes associated with pathogens, enabling a much more definitive diagnosis.

Molecular tests can identify infectious agents such as HPV, Chlamydia trachomatis/Neisseria gonorrhea (CT/NG), and tuberculosis. Moreover, these tests are increasingly being used to detect genes associated with resistance to healthcare-related infections and disease-resistant pathogens. Rapid immunoassays employing lateral flow immunochromatographic techniques are being developed to allow detection of an increasing array of infectious diseases at point-of-care locations, including clinics, doctors' offices, hospital emergency rooms, and patient homes. Specific tests now available in this area include ones for bacterial vaginosis (BV), chlamydia, dengue, Ebola, HIV, influenza, Legionnaires' disease, malaria, rotavirus, respiratory syncytial virus (RSV), group A Streptococcus, Treponema pallidum, and Trichomonas vaginalis. The sources for specimens for rapid immunoassays encompass a wide variety of substances, such as whole blood, serum, urine, nasal and throat swabs, stool samples, and vaginal swabs.

Related Links:
Kalorama Information

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Anesthesia Cart
UMGSA-33369-VIL

Print article

Channels

Critical Care

view channel
Image: AI can be as good as a physician at prioritizing which patients need to be seen first (Photo courtesy of 123RF)

AI Can Prioritize Emergecny Department Patients Requiring Urgent Treatment

Emergency departments across the world are facing severe overcrowding and excessive demands, but a new study indicates that artificial intelligence (AI) might soon assist in prioritizing patients who require... Read more

Surgical Techniques

view channel
Image: The robot`s segments can flatten and extend into cylinders (Photo courtesy of Princeton)

Caterpillar Robot with Built-In Steering System Crawls Easily Through Loops and Bends

Soft robots often face challenges in being guided effectively because adding steering mechanisms typically reduces their flexibility by increasing rigidity. Now, a team of engineers has combined ancient... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more